Last reviewed · How we verify
NCT06087562
iPACK Block for Total Knee Arthroplasty
Phase 4 trial testing Ropivacaine 0.5% Injectable Solution 20mL in Knee Osteoarthritis in 350 participants. Status unknown.
30 September 2024
Quick facts
| Lead sponsor | Poznan University of Medical Sciences |
|---|---|
| Phase | Phase 4 |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | triple |
| Primary purpose | treatment |
| Enrollment | 350 |
| Start date | 16 June 2020 |
| Primary completion | 30 September 2024 |
| Estimated completion | 30 December 2024 |
| Sites | 1 location across Poland |
Drugs / interventions tested
- Ropivacaine 0.5% Injectable Solution 20mL — full drug profile →
- 0,9% normal saline 20mL — full drug profile →
Conditions studied
- Knee Osteoarthritis — all drugs for Knee Osteoarthritis →
- Knee Pain Chronic — all drugs for Knee Pain Chronic →
- Knee Disease — all drugs for Knee Disease →
Sponsor
Poznan University of Medical Sciences
Who can join
Adults 18 to 100, any sex, with Knee Osteoarthritis or Knee Pain Chronic. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This randomized, double-blinded, placebo-controlled trial seeks to evaluate the efficacy of the rehabilitation process of the Interspace between the Popliteal Artery and Capsule of the Posterior Knee (iPACK) block in total knee arthroplasty.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06087562
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Knee Osteoarthritis
Currently open trials in the same condition.
- NCT06906939 — A Randomized Pilot rTMS Trial for Knee Arthritis Pain and Depression · EARLY_PHASE1 · recruiting
- NCT05823727 — Effects of Collagen Peptide Supplementation on Connective Tissue Remodeling, Functional Outcomes, and Wound Healing Afte · NA · recruiting
- NCT07370480 — Knee Osteoarthritis and Thermal Spa Treatment · NA · recruiting
- NCT07507175 — Gastrocnemius Myofascial Release in Females With Knee Osteoarthritis · NA · recruiting
- NCT07386600 — Dexamethasone vs Dexmedetomidine for iPACK + ACB in TKA · NA · recruiting
Other Poznan University of Medical Sciences trials
Trials by the same sponsor.
- NCT07449468 — PENG Block and Delirium After Hip Arthroplasty · NA · not yet recruiting
- NCT07449442 — SII Levels Following iPACK Block With Adductor Canal Block in Knee Arthroplasty · NA · not yet recruiting
- NCT07474896 — Diaphragm-Sparing Regional Anesthesia Techniques for Shoulder Surgery · NA · not yet recruiting
- NCT07474909 — Perineural vs Intravenous Dexamethasone as an Adjuvant to Brachial Plexus Block in Pediatric Hand Surgery · NA · not yet recruiting
- NCT07449403 — SII Levels Following PENG Block in Hip Arthroplasty · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06087562 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Poznan University of Medical Sciences
- Last refreshed: 18 October 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06087562.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing